The FDA has approved the first permanent implant to relieve low or blocked urine flow in men aged 50 years and older with benign prostatic hyperplasia (BPH). Manufactured by NeoTract, the UroLift ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has revealed that the now-available test remains just as accurate without it, paving ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common form of kidney cancer, researchers reported at the 2025 annual congress of ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...